Catalent Expands Analytical Services Capabilities with a New Lab in Swindon, UK

This expansion comes soon after the recently expanded clinical supply service capabilities in Schorndorf, Germany.

“This is part of Catalent's continuous investment to strengthen our position as the #1 global partner for drug development and formulation services,” commented Scott Houlton, President of Catalent's Development & Clinical Services business. “Our customers have asked for expanded testing services in Europe, and value the expertise and security that come from working with a company with the depth and breadth of Catalent. This expansion will enable us to better meet customer needs in Europe for analytical testing, including clinical and commercial release testing of their products.”

Catalent has over 20 years of proven industry experience providing Analytical Development Services in the US from Research Triangle Park, NC. Catalent provides a broad range of CMC and analytical testing for both small and large molecule drugs. This new laboratory is located within Catalent's Swindon campus, joining the development and commercial supply operations for Catalent's market-leading oral fast dissolve Zydis® technology.

The laboratory systems being implemented are designed to meet regulatory requirements in the EU, US and other major markets. The lab services initially offered include:

• Raw material and finished product release testing
• Qualified Person release
• Method development and validation
• Compendial testing
• Microbiology
• Stability testing and storage

For more information on Catalent development and analytical services, please click here.